Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Breast Cancer Research and Treatment|January 9, 2023
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancerMatthew Loft, Sheau Wen Lok, Richard De Boer, et al.Breast Cancer Research and Treatment|August 12, 2020
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancerYada Kanjanapan, Sheau Wen Lok, Peter Gibbs, et al.Clinical Breast Cancer|August 8, 2022
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based StudyIris Tung, Cristina Moldovan, Vanessa Wong, et al.Frontiers in Immunology|July 3, 2020
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES SwitchWen Juan Tu, Robert D McCuaig, Abel H Y Tan, et al.Journal for Immunotherapy of Cancer|September 17, 2021
Simple and effective bacterial-based intratumoral cancer immunotherapyChristina S E Carroll, Erin R Andrew, Laeeq Malik, et al.Cancers|March 25, 2022
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8<sup>+</sup> T Cells in Immunotherapy-Resistant and Metastatic CancersJenny Dunn, Robert D McCuaig, Abel H Y Tan, et al.Molecular Cancer Therapeutics|June 11, 2025
Depleting the action of EZH2 through PI3K-mTOR inhibition to overcome metastasis and immunotherapy resistance in triple-negative breast cancerMichelle Melino, Wen Juan Tu, Helle Bielefeldt-Ohmann, et al.Pageof 3